Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen R Laird

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Current Opinion in Drug Discovery & Development|June 26, 2004
Structure-based generation of viable leads from small combinatorial librariesEllen R Laird, James F Blake
Biochemistry|June 26, 2002
Engineering autoactivating forms of matrix metalloproteinase-9 and expression of the active enzyme in cultured cells and transgenic mouse brainKatherine E Fisher, Qing Fei, Ellen R Laird, et al.
Bioorganic & Medicinal Chemistry Letters|September 8, 2012
Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: rational design and kinase selectivity profile of cell potent type II inhibitorsSteve Wenglowsky, David Moreno, Ellen R Laird, et al.
Future Medicinal Chemistry|November 13, 2013
5-alkyl-1,3-oxazole derivatives of 6-amino-nicotinic acids as alkyl ester bioisosteres are antagonists of the P2Y12 receptorPeter Bach, Jonas Boström, Kay Brickmann, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-Raf(V600E) kinase with favorable physicochemical and pharmacokinetic propertiesLi Ren, Ellen R Laird, Alex J Buckmelter, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2013
Imidazo[4,5-b]pyridine inhibitors of B-Raf kinaseBradley J Newhouse, Steve Wenglowsky, Jonas Grina, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2007
Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitorsC Todd Eary, Zachary S Jones, Robert D Groneberg, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2009
Novel N-substituted 2-phenyl-1-sulfonylamino-cyclopropane carboxylates as selective ADAMTS-5 (Aggrecanase-2) inhibitorsMakoto Shiozaki, Katsuya Maeda, Tomoya Miura, et al.
Biochemistry|March 19, 2003
Specificity determinants of human cathepsin s revealed by crystal structures of complexesThomas A Pauly, Traian Sulea, Mark Ammirati, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2011
The discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitorsAlex J Buckmelter, Li Ren, Ellen R Laird, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Opinion in Drug Discovery & Development|June 26, 2004
Structure-based generation of viable leads from small combinatorial librariesEllen R Laird, James F Blake
Biochemistry|June 26, 2002
Engineering autoactivating forms of matrix metalloproteinase-9 and expression of the active enzyme in cultured cells and transgenic mouse brainKatherine E Fisher, Qing Fei, Ellen R Laird, et al.
Bioorganic & Medicinal Chemistry Letters|September 8, 2012
Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: rational design and kinase selectivity profile of cell potent type II inhibitorsSteve Wenglowsky, David Moreno, Ellen R Laird, et al.
Future Medicinal Chemistry|November 13, 2013
5-alkyl-1,3-oxazole derivatives of 6-amino-nicotinic acids as alkyl ester bioisosteres are antagonists of the P2Y12 receptorPeter Bach, Jonas Boström, Kay Brickmann, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-Raf(V600E) kinase with favorable physicochemical and pharmacokinetic propertiesLi Ren, Ellen R Laird, Alex J Buckmelter, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2013
Imidazo[4,5-b]pyridine inhibitors of B-Raf kinaseBradley J Newhouse, Steve Wenglowsky, Jonas Grina, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2007
Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitorsC Todd Eary, Zachary S Jones, Robert D Groneberg, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2009
Novel N-substituted 2-phenyl-1-sulfonylamino-cyclopropane carboxylates as selective ADAMTS-5 (Aggrecanase-2) inhibitorsMakoto Shiozaki, Katsuya Maeda, Tomoya Miura, et al.
Biochemistry|March 19, 2003
Specificity determinants of human cathepsin s revealed by crystal structures of complexesThomas A Pauly, Traian Sulea, Mark Ammirati, et al.
Bioorganic & Medicinal Chemistry Letters|January 8, 2011
The discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitorsAlex J Buckmelter, Li Ren, Ellen R Laird, et al.
Pageof 4